Standard

PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA. / Kolbin, A.; Frolov, M.; Kurylev, A.; Balykina, Y.; Proskurin, M.

In: Value in Health, Vol. 18, No. 7, 11.2015, p. A442-A442.

Research output: Contribution to journalMeeting Abstractpeer-review

Harvard

APA

Vancouver

Author

BibTeX

@article{914282bbe89644798b8a57d6278e0f4e,
title = "PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA",
author = "A. Kolbin and M. Frolov and A. Kurylev and Y. Balykina and M. Proskurin",
year = "2015",
month = nov,
language = "Английский",
volume = "18",
pages = "A442--A442",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier",
number = "7",

}

RIS

TY - JOUR

T1 - PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

AU - Kolbin, A.

AU - Frolov, M.

AU - Kurylev, A.

AU - Balykina, Y.

AU - Proskurin, M.

PY - 2015/11

Y1 - 2015/11

M3 - тезисы

VL - 18

SP - A442-A442

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 7

ER -

ID: 9440446